Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis

Authors: Benjamin Ng, Jinrui Dong, Giuseppe D’Agostino, Sivakumar Viswanathan, Anissa A. Widjaja, Wei-Wen Lim, Nicole S. J. Ko, Jessie Tan, Sonia P. Chothani, Benjamin Huang, Chen Xie, Chee Jian Pua, Ann-Marie Chacko, Nuno Guimarães-Camboa, Sylvia M. Evans, Adam J. Byrne, Toby M. Maher, Jiurong Liang, Dianhua Jiang, Paul W. Noble, Sebastian Schafer, Stuart A. Cook

Published: 2019-09-25

DOI: 10.1126/scitranslmed.aaw1237

Source: Full article


Abstract

Interleukin-11 is important for lung fibroblast activation in idiopathic pulmonary fibrosis, and its signaling represents a therapeutic target.